ACHE and Alzheimer disease: The conjugation of the active moiety of rivastigmine with 2 isomeric hydroxyphenylbenzimidazole results in novel hybrids of rivastigmine with anti-AD properties, including AChE and BuChE inhibitory activity, metal chelation, antioxidation, and inhibition of Aβ aggregation [86].